Home
Live Updates
Adela Presents Data Demonstrating Ability of Tissue-Agnostic MRD Assay to Predict Recurrence in Head & Neck Cancer at the American Association for Cancer Research Annual Meeting 2024 : vimarsana.com
Adela Presents Data Demonstrating Ability of Tissue-Agnostic MRD Assay to Predict Recurrence in Head & Neck Cancer at the American Association for Cancer Research Annual Meeting 2024
/PRNewswire/ -- Adela, Inc., an innovator in blood testing for minimal residual disease monitoring and early cancer detection through a proprietary genome-wide...
Related Keywords
Canada ,
United States ,
Toronto ,
Ontario ,
American ,
Geoffrey Liu ,
Scientist At Princess Margaret Cancer Centre ,
University Health Network ,
Adela Inc ,
Princess Margaret Cancer Centre ,
Prnewswire Adela Inc ,
American Association For Cancer Research ,
American Association ,
Cancer Research ,
Annual Meeting ,
Scott Bratman ,
Chief Innovation Officer ,
Radiation Oncologist ,
University Health ,
Board Number ,
F Prime Capital ,
Deerfield Management ,
Decheng Capital ,
Margaret Cancer Centre ,
Foster City ,
Nadela ,
vimarsana.com © 2020. All Rights Reserved.